kinin
famili
vasoact
peptid
implic
cardiovascular
regul
inflamm
nocicept
effect
mediat
activ
two
g
proteincoupl
receptor
receptor
bind
bradykinin
high
affin
rodent
human
prefer
agonist
kallidin
lysbradykinin
receptor
favor
carboxymetabolit
desarg
bradykinin
rodent
desarg
kallidin
human
receptor
constitut
entiti
receptor
induc
molecul
may
upregul
special
circumst
receptor
put
good
guy
modul
blood
coagul
exert
antithrombot
profibrinolyt
action
signal
releas
nitric
oxid
prostacyclin
therebi
inhibit
vascular
smooth
muscl
cell
growth
neointim
format
action
could
slow
develop
atherosclerosi
diabetesmedi
target
organ
damag
receptor
induc
proinflammatori
element
includ
endotoxin
lipopolysaccharid
cytokin
receptor
agonist
innat
immun
pain
obvious
import
defens
mechan
howev
induc
receptor
becom
desir
drug
target
respons
held
check
upregul
receptor
rather
novel
featur
inflammatori
pathway
receptor
gene
promot
outfit
nuclear
factorkappab
bind
site
play
regulatori
role
particularli
receptor
upregul
respons
beta
tumor
necrosi
factoralpha
lipopolysaccharid
lp
schema
suggest
calixto
et
al
shown
outlin
form
fig
merino
et
al
report
issu
overexpress
receptor
endotheli
cell
transgen
rat
increas
suscept
endotox
lpsmediat
shock
endotheliumspecif
express
achiev
use
mous
promoterenhanc
entir
kb
transgen
fragment
introduc
pronuclei
fertil
zygot
spragu
dawley
rat
ribonucleas
protect
assay
confirm
gener
endotheli
express
transgen
multipl
organ
receptor
express
constitut
sinc
desarg
elicit
dosedepend
aortic
relax
transgen
rat
effect
abolish
endotheli
remov
effect
influenc
tetraethylammonium
oubain
suggest
particip
potassium
channel
sodiumpotassium
atpas
cytochrom
enzym
prostaglandin
involv
desarg
bradykinin
lower
blood
pressur
otherwis
normotens
transgen
rat
effect
nitric
oxidedepend
sinc
synthas
inhibitor
diminish
effect
next
author
perform
vascular
permeabl
studi
evan
blue
administ
via
tail
vein
desarg
result
dye
extravas
final
stage
set
lp
experi
transgen
control
rat
inject
lp
transgen
rat
becam
hypotens
half
anim
die
compar
death
among
control
result
surpris
mous
gener
transgen
receptor
model
alreadi
shown
increas
receptor
express
increas
propens
lpsmediat
shock
fact
receptor
longer
first
upregul
express
great
abund
also
favor
posit
result
studi
author
claim
endothelialspecif
target
novelti
studi
anyth
els
learn
model
model
could
use
drug
kinin
famili
vasoact
peptid
implic
cardiovascular
regul
inflamm
nocicept
effect
mediat
activ
two
g
proteincoupl
receptor
receptor
bind
bradykinin
high
affin
rodent
human
prefer
agonist
kallidin
lysbradykinin
receptor
favor
carboxymetabolit
desarg
bradykinin
rodent
desarg
kallidin
human
receptor
constitut
entiti
receptor
induc
molecul
may
upregul
special
circumst
receptor
put
good
guy
modul
blood
coagul
exert
antithrombot
profibrinolyt
action
signal
releas
nitric
oxid
prostacyclin
therebi
inhibit
vascular
smooth
muscl
cell
growth
neointim
format
action
could
slow
develop
atherosclerosi
diabetesmedi
target
organ
damag
receptor
induc
proinflammatori
element
includ
endotoxin
lipopolysaccharid
cytokin
receptor
agonist
innat
immun
pain
obvious
import
defens
mechan
howev
induc
receptor
becom
desir
drug
target
respons
held
check
upregul
receptor
rather
novel
featur
inflammatori
pathway
receptor
gene
promot
outfit
nuclear
factorkappab
bind
site
play
regulatori
role
particularli
receptor
upregul
respons
beta
tumor
necrosi
factoralpha
lipopolysaccharid
lp
schema
suggest
calixto
et
al
shown
outlin
form
fig
merino
et
al
report
issu
overexpress
receptor
endotheli
cell
transgen
rat
increas
suscept
endotox
lpsmediat
shock
endotheliumspecif
express
achiev
use
mous
promoterenhanc
entir
kb
transgen
fragment
introduc
pronuclei
fertil
zygot
spragu
dawley
rat
ribonucleas
protect
assay
confirm
gener
endotheli
express
transgen
multipl
organ
receptor
express
constitut
sinc
desarg
elicit
dosedepend
aortic
relax
transgen
rat
effect
abolish
endotheli
remov
effect
influenc
tetraethylammonium
oubain
suggest
particip
potassium
channel
sodiumpotassium
atpas
cytochrom
enzym
prostaglandin
involv
desarg
bradykinin
lower
blood
pressur
otherwis
normotens
transgen
rat
effect
nitric
oxidedepend
sinc
synthas
inhibitor
diminish
effect
next
author
perform
vascular
permeabl
studi
evan
blue
administ
via
tail
vein
desarg
result
dye
extravas
final
stage
set
lp
experi
transgen
control
rat
inject
lp
transgen
rat
becam
hypotens
half
anim
die
compar
death
among
control
result
surpris
mous
gener
transgen
receptor
model
alreadi
shown
increas
receptor
express
increas
propens
lpsmediat
shock
fact
receptor
longer
first
upregul
express
great
abund
also
favor
posit
result
studi
author
claim
endothelialspecif
target
novelti
studi
anyth
els
learn
model
model
could
use
drug
develop
peptiderg
receptor
antagonist
around
sinc
subject
proteolyt
degrad
potenti
antigen
howev
nonpeptiderg
receptor
antagonist
undergo
studi
one
potenti
exampl
novel
benzamid
receptor
antagonist
undecanecarbonyl
phenyl
speci
specif
could
problem
sinc
merino
et
al
reli
mous
human
construct
potent
primat
rodent
receptor
furthermor
septic
shock
complic
entiti
antagonist
might
brighter
futur
manag
neuropath
pain
altern
use
model
might
studi
reninangiotensin
system
aspartylproteas
renin
cleav
angiotensinogen
angiotensin
ang
convert
activ
agonist
ang
ii
angiotensin
convert
enzym
ace
ace
also
known
kininas
ii
origin
describ
degrad
bradykinin
ace
inhibitor
commonli
use
cardiovascular
medicin
effect
part
attribut
action
hinder
degrad
bradykinin
relationship
kinin
system
reninangiotensin
system
mean
stop
recent
ceravolo
et
al
observ
infus
ang
ii
induc
receptor
express
aorta
rat
furthermor
ignjatov
et
al
observ
ace
inhibitor
activ
receptor
latter
observ
particularli
interest
sinc
activ
occur
absenc
ace
absenc
desargkinin
name
agonist
ignjatov
et
al
found
receptor
contain
znbind
pentamer
consensu
sequenc
absent
receptor
model
develop
merino
et
al
go
shock
treat
ace
inhibitor
given
ang
ii
receptor
blocker
ace
also
cross
talk
kinin
receptor
benz
et
al
show
ace
inhibitor
enhanc
vascular
respons
bradykinin
influenc
distribut
receptor
within
plasma
membran
howev
find
directli
relev
discuss
anoth
interact
could
studi
lpsinduc
shock
model
shown
studi
ace
express
express
anoth
matrix
metalloproteinas
convert
ang
ii
ang
heptapeptid
effect
total
differ
ang
ii
name
blood
pressur
lower
vasodilatori
antiprolif
also
serv
corona
viru
receptor
pulmonari
epithelium
gupta
et
al
recent
observ
activ
protein
c
amelior
lpsinduc
renal
injuri
downregul
inflammatori
synthas
ace
express
instead
activ
protein
c
upregul
express
increas
ang
protect
acut
respiratori
distress
syndrom
suggest
merino
et
al
someth
transgen
rat
event
arm
suggest
counter
deadli
question
studi
done
respect
friedrich
c
luft
fig
possibl
mechan
receptor
upregul
shown
lp
stimul
tolllik
receptor
tlr
cytokin
growth
factor
even
agonist
upregul
otherwis
constitut
receptor
seri
kinas
perform
intermedi
signal
transcript
factor
involv
includ
ccaatenhanc
bind
protein
creb
activ
nuclear
factorkappab
adapt
